Literature DB >> 18591008

Intermediate scale for assessment of Parkinson's disease. Characteristics and structure.

P Martínez-Martin, A Gil-Nagel, L Morlán Gracia, J Balseiro Gómez, F J Martínez-Sarriés, F Bermejo, T Del Ser Quijano, M C Macías, C Jiménez-Rojas, E Marañón, J M Grau Veciana, C Roig Arnall, O Bruna, C Junquéplaja, S Giménez-Roldán, J A Burguera.   

Abstract

The present study is devoted to the verification of the basic metrical characteristics of the ISAPD. One hundred and sixty-seven Parkinson's disease (PD) patients were included. Group A (n = 40) was simultaneously assessed by five raters who applied the ISAPD and other PD rating scales (PDRS). A set of timed tests, the MiniMental State Examination (MMSE) and the Hamilton Scale for Depression (HSD) were administered by an independent examiner. Group B (n = 127) was individually assessed through the UPDRS and the other PDRSs by separate neurologists in four different hospitals. The ISAPD was administered in 7.0 +/- 3.7 min. The internal consistency of this scale was high (Cronbach's alpha = 0.97). The inter-rater reliability of their items was very satisfactory (for all items, kappa > 0.70). There was a high correlation with the Hoehn and Yahr classification (r(s) = 0.71; p < 0.001) and some timed tests. The convergent validity with the other PDRS (UPDRS and Schwab and England Scale) was also very high (r(s) = 0.83-0.92; p < 0.001). The ISAPD also correlated with the MMSE and the HSD. Factor analysis identified three factors (activities of daily living; gait and mobility; speech and eating) that explained 76% of the variance. The ISAPD is an easy to apply, reliable, and valid scale that fulfills the aim for which it was designed.

Entities:  

Year:  1995        PMID: 18591008     DOI: 10.1016/1353-8020(95)00002-x

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

Review 1.  Late-stage Parkinson disease.

Authors:  Miguel Coelho; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2012-07-10       Impact factor: 42.937

2.  Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS).

Authors:  Pablo Martinez-Martin; Maria Jose Catalan; Julian Benito-Leon; Angel Ortega Moreno; Ivana Zamarbide; Esther Cubo; Nadeje van Blercon; Victor Campos Arillo; Margarita Pondal; Gurutz Linazasoro; Fernando Alonso; Pedro García Ruiz; Belen Frades
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

3.  Quality of life of caregivers in Parkinson's disease.

Authors:  Pablo Martínez-Martín; Julián Benito-León; Fernando Alonso; M José Catalán; M Pondal; I Zamarbide; A Tobías; J de Pedro
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

4.  Trunk muscle exercises as a means of improving postural stability in people with Parkinson's disease: a protocol for a randomised controlled trial.

Authors:  Ryan P Hubble; Geraldine A Naughton; Peter A Silburn; Michael H Cole
Journal:  BMJ Open       Date:  2014-12-31       Impact factor: 2.692

5.  Activities of daily living questionnaire from patients' perspectives in Parkinson's disease: a cross-sectional study.

Authors:  Su-Yun Lee; Sung Kwan Kim; Sang-Myung Cheon; Jung-Wook Seo; Min Ah Kim; Jae Woo Kim
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.